Comprehensive strategies for breast reconstruction after mastectomy: Integrating autologous flaps, implants and emerging technologies

Breast cancer is the most prevalent malignancy among women worldwide, with mastectomy being a cornerstone of treatment despite its profound physical and psychological impact. Breast reconstruction has emerged as a critical component of holistic cancer care, with the goal of restoring body image, enhancing quality of life, and mitigating emotional distress. This review summarizes the key techniques, timing and outcomes, complications, patient-centered care and future directions of reconstruction techniques. The selection of a reconstructive technique should be highly individualized, based on a comprehensive evaluation within a multidisciplinary framework. Autologous tissue reconstruction (e.g., TRAM, DIEP, LD, and SGAP flaps) offers natural aesthetics and durability but has a long recovery time and is associated with donor-site morbidity. DIEP flaps, which preserve abdominal muscle function, have largely replaced traditional TRAM flaps because of lower complication rates. Implant-based reconstruction provides shorter operative times and faster recovery but is associated with risks of capsular contracture, rupture, and needing secondary surgeries. Innovations such as acellular dermal matrices and prepectoral placement can improve outcomes. Hybrid approaches combine implants with autologous tissue for volume and a natural feel, although they also increase the complexity of the surgical procedure. Emerging technologies include fat grafting (enhanced with stem cells for graft survival) and 3D-printed scaffolds for personalized reconstruction. Immediate reconstruction reduces psychological trauma but may conflict with radiotherapy scheduling. Delayed reconstruction is preferred for patients who require radiation, with optimal outcomes observed when the reconstruction is performed ≥6 months post-radiotherapy. Early issues (infection, hematoma) and late challenges (capsular contracture, fat necrosis) are discussed, emphasizing preventive strategies such as indocyanine green angiography for flap perfusion assessment. Multidisciplinary teams (MDTs) optimize decision-making by integrating oncologic safety, patient preferences, and psychosocial support. Long-term studies highlight superior satisfaction with autologous flaps despite higher initial morbidity. Bioengineered implants, AI-assisted surgical planning, and real-time monitoring technologies promise to improve precision and outcomes. This article aims to provide healthcare professionals with up-to-date insights and individualized treatment strategies to improve patient outcomes and quality of life.